These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

523 related items for PubMed ID: 18177455

  • 21. Molecular mechanisms and therapeutic targets in steatosis and steatohepatitis.
    Anderson N, Borlak J.
    Pharmacol Rev; 2008 Sep; 60(3):311-57. PubMed ID: 18922966
    [Abstract] [Full Text] [Related]

  • 22. Nonalcoholic fatty liver disease: from clinical recognition to treatment.
    Sevastianos VA, Hadziyannis SJ.
    Expert Rev Gastroenterol Hepatol; 2008 Feb; 2(1):59-79. PubMed ID: 19072371
    [Abstract] [Full Text] [Related]

  • 23. Natural history of nonalcoholic steatohepatitis.
    Liou I, Kowdley KV.
    J Clin Gastroenterol; 2006 Mar; 40 Suppl 1():S11-6. PubMed ID: 16540761
    [Abstract] [Full Text] [Related]

  • 24. Nonalcoholic fatty liver disease as a contributor to hypercoagulation and thrombophilia in the metabolic syndrome.
    Targher G, Chonchol M, Miele L, Zoppini G, Pichiri I, Muggeo M.
    Semin Thromb Hemost; 2009 Apr; 35(3):277-87. PubMed ID: 19452403
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. The natural history and risk factors for progression of non-alcoholic fatty liver disease and steatohepatitis.
    Miele L, Forgione A, Hernandez AP, Gabrieli ML, Vero V, Di Rocco P, Greco AV, Gasbarrini G, Gasbarrini A, Grieco A.
    Eur Rev Med Pharmacol Sci; 2005 Apr; 9(5):273-7. PubMed ID: 16231589
    [Abstract] [Full Text] [Related]

  • 32. The pathogenesis of nonalcoholic steatohepatitis and other fatty liver diseases: a four-step model including the role of lipid release and hepatic venular obstruction in the progression to cirrhosis.
    Wanless IR, Shiota K.
    Semin Liver Dis; 2004 Feb; 24(1):99-106. PubMed ID: 15085490
    [Abstract] [Full Text] [Related]

  • 33. Nonalcoholic fatty liver disease: pathogenesis and potential for nuclear receptors as therapeutic targets.
    George J, Liddle C.
    Mol Pharm; 2008 Feb; 5(1):49-59. PubMed ID: 18072723
    [Abstract] [Full Text] [Related]

  • 34. Treatment strategies in nonalcoholic fatty liver disease.
    Tilg H, Kaser A.
    Nat Clin Pract Gastroenterol Hepatol; 2005 Mar; 2(3):148-55. PubMed ID: 16265156
    [Abstract] [Full Text] [Related]

  • 35. Nonalcoholic fatty liver disease.
    Adams LA, Lindor KD.
    Ann Epidemiol; 2007 Nov; 17(11):863-9. PubMed ID: 17728149
    [Abstract] [Full Text] [Related]

  • 36. Evolving trends in nonalcoholic fatty liver disease.
    Delgado JS.
    Eur J Intern Med; 2008 Mar; 19(2):75-82. PubMed ID: 18249301
    [Abstract] [Full Text] [Related]

  • 37. Mechanisms of disease progression in nonalcoholic fatty liver disease.
    Jou J, Choi SS, Diehl AM.
    Semin Liver Dis; 2008 Nov; 28(4):370-9. PubMed ID: 18956293
    [Abstract] [Full Text] [Related]

  • 38. Pathogenesis of non-alcoholic steatohepatitis: human data.
    Edmison J, McCullough AJ.
    Clin Liver Dis; 2007 Feb; 11(1):75-104, ix. PubMed ID: 17544973
    [Abstract] [Full Text] [Related]

  • 39. Role of fatty acids in the pathogenesis of obesity and fatty liver: impact of bariatric surgery.
    Verna EC, Berk PD.
    Semin Liver Dis; 2008 Nov; 28(4):407-26. PubMed ID: 18956297
    [Abstract] [Full Text] [Related]

  • 40. Review article: the pathogenesis of fibrosis in non-alcoholic steatohepatitis.
    Marra F, Aleffi S, Bertolani C, Petrai I, Vizzutti F.
    Aliment Pharmacol Ther; 2005 Nov; 22 Suppl 2():44-7. PubMed ID: 16225472
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 27.